Clinical Trials Logo

Aneurysm clinical trials

View clinical trials related to Aneurysm.

Filter by:

NCT ID: NCT01526811 Completed - Clinical trials for Cardiovascular Diseases

Endurantâ„¢ Stent Graft System in the Treatment of Infra-renal Abdominal Aortic Aneurysms (ENDURANT France)

Start date: March 2012
Phase:
Study type: Observational

The purpose of this study is to assess the benefits of endovascular repair with Endurant Stent Graft System by documenting overall mortality, complications, the rate of conversion to open surgical repair, and the development and rupture of the aneurysm on a long term, i.e. at 5 years, in a cohort of patients representative of the population treated under real-life conditions of use in France.

NCT ID: NCT01524211 Recruiting - Clinical trials for Thoracoabdominal Aortic Aneurysm

Evaluation of Branch Endografts in the Treatment of Aortic Aneurysms

Start date: January 25, 2012
Phase: N/A
Study type: Interventional

Zenith t-Branch Study Cohort: The purpose of this study is to collect information on the Cook Zenith t-Branch endovascular stent-graft system and the Terumo Arch Branch for the treatment of aortic aneurysms. Terumo Arch Branch Study Cohort: The purpose of this additional study arm to the current IDE clinical trial is to collect a priori information on the Terumo Arch Branch Endograft for the treatment of proximal thoracic aortic pathologies that cannot be treated with conventional thoracic endografts.

NCT ID: NCT01523262 Recruiting - Aortic Aneurysm Clinical Trials

Preventing Myocardial Ischemia by Preconditioning in Elective Operation for Abdominal Aortic Aneurysm

Start date: January 2011
Phase: Phase 1
Study type: Interventional

Primary To investigate whether peripheral predonditioning induced by brief, intermittent constriction of blood supply to an arm can reduce the incidence of perioperative myocardial ischemia in patients operated electively for infrarenal aortic aneurysm. Secondary To investigate the impact of peripheral preconditioning on perioperative inflammatory response. To investigate whether peripheral preconditoning can protect against perioperative myocardial infarction and reduced cardiac pump function.

NCT ID: NCT01516658 Completed - Clinical trials for Subarachnoid Hemorrhage

HYdrogel Coil Versus Bare Platinum Coil in Recanalization Imaging Data Study

HYBRID
Start date: June 2012
Phase: N/A
Study type: Interventional

HYBRID study is prospective randomized open label controlled multi center trial, to compare Hydrocoil and bare platinum coil for recanalization after endovascular treatment of intracranial aneurysms.

NCT ID: NCT01505738 Completed - Aneurysm Clinical Trials

Bacterial Growth in Vascular Surgery Wounds

Start date: January 2012
Phase: N/A
Study type: Observational

The amount and species of bacteria have been shown to have an effect in wound infections in several fields of surgery (such as gastrointestinal and orthopaedic surgery and the surgery of facial area). In vascular surgery, wound infections are a common and expensive complication. The aim of the present study is to investigate the prevalence of bacteria in vascular surgery wounds perioperatively, and determine whether is correlates with the incidence of wound infections postoperatively.

NCT ID: NCT01503775 Completed - Aneurysms Clinical Trials

TRUfill®'s Line in Intracranial aNeurysm Embolisation

TRULINE
Start date: December 1, 2011
Phase: N/A
Study type: Observational

The objective of this study is to evaluate the long term efficacy and safety of the CODMAN TRUFILL®'s line of coils in the treatment of patients with intracranial ruptured or non-ruptured aneurysms in real-life routine clinical practice.

NCT ID: NCT01491945 Completed - Clinical trials for Abdominal Aortic Aneurysm

Safety and Effectiveness Trial of the Ventana Fenestrated Stent Graft System

Start date: March 3, 2013
Phase: N/A
Study type: Interventional

The purpose of this trial is to determine if the Ventana Fenestrated Stent Graft System is safe and effective for the endovascular repair of juxtarenal or pararenal aortic aneurysms.

NCT ID: NCT01490463 Completed - Clinical trials for Unruptured Intracranial Aneurysms

Brain Lesions Following Endovascular and Surgical Treatment of Unruptured Intracranial Aneurysms

LESUIA
Start date: August 2011
Phase: N/A
Study type: Observational

The purpose of this study is to determine the incidence and impact of brain lesions in MRI after coiling and clipping of unruptured intracranial aneurysms on clinical and neurological outcome of patients.

NCT ID: NCT01480531 Withdrawn - Aorta Aneurysm Clinical Trials

Pre and or Post Operative Blood Pressure Control With Clevidipine (Cleviprexm Medicines Company) in Aortic Aneurysm / Dissection

Clevidipine
Start date: December 2011
Phase: N/A
Study type: Interventional

2. Purpose of the Study - 1. To determine the feasibility of Clevidipine use for rapidly achieving and maintaining individually specified patient BP target ranges in the pre and postoperative periods of aortic aneurysm and dissection management. 2. To determine the safety of Clevidipine use in the pre and postoperative periods of aneurysm and dissection management 3. Background & Significance - Surgical treatments for persons with aortic root/arch dissection or aneurysm have significantly improved survival. However, critical in management of these patients is precise control of blood pressure (BP). With increasing BP, both acute and chronic, the risk of fatal and nonfatal vascular complications is imminent. Similarly, with excessive lowering of arterial pressures, cerebral, spinal cord, cardiac, and renal ischemic hypoperfusion is also noteworthy. Typically, the target systolic blood pressure range for these patients is 100-120 mmHg. Several different classes of vasoactive agents are in current use to acutely manage BP but none possess the optimal profile of an ideal vasodilator. Notable limitations include inadequate potency, slow onset and offset of action, multiple receptor function, safety concerns and, importantly, restricted/ineffective titration, which results in clinically significant hemodynamic and cardiovascular perturbations. Recently, the ultra short-acting intravenous dihydropyridine calcium-channel blocker clevidipine (Cleviprex, The Medicines Company) was approved for management of BP in critical care settings. Clevidipine's pharmacology lends itself to acute management of BP in a broad critical care setting in both surgical and nonsurgical patients. In the current study, the investigators propose to further characterize the hemodynamic effect of CLV in the pre and post-operative management of BP in patients with aortic aneurysm/dissection. 4. Design & Procedures Eligible patients will be approached to participate in the study by the Intensive Care Unit (ICU) attending and/or by a cardiothoracic surgical/anesthesiology fellow or a cardiac research nurse. All aspects of clinical management and monitoring will be according to standard practice that includes: - ECG - Oxymetry - Temperature - Invasive arterial blood pressure - Recording of routine laboratory results - Imaging studies including CT/MRI (A)/ Echocardiography - Pulmonary artery catheter (postoperative patients) - Mechanical ventilation (postoperative patients) - According to established protocol for acute intravenous management of arterial blood pressure in these patients, an upper and lower threshold of systolic blood pressure will be prescribed by the attending physician (the range being (100 mmHg -120 mm Hg SBP). Hemodynamic data will be collected continuously via a bedside laptop as well as pertinent clinical data and information about efficacy and safety will be recorded. • Subjective evaluation of efficacy of CLV (questionnaire format to be completed by the critical care team)

NCT ID: NCT01480206 Completed - Carotid Stenosis Clinical Trials

Overlay of 3D Scans on Live Fluoroscopy for Endovascular Procedures in the Hybrid OR

Start date: September 13, 2011
Phase:
Study type: Observational

As endovascular procedures become more complex, there is a growing need for 3D image overlay to assist with device guidance and placement. Currently, a 3D image is typically created intra-operatively using 3D rotational angiography (3D-RA) or cone-beam CT (XperCT). This 3D image may then be overlaid on live fluoroscopy to provide 3D guidance information (Dynamic 3D Roadmapping). Philips Healthcare multimodality overlay products allows registration of a pre-acquired MR/CT or 3D rotational image to live fluoroscopy.